Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Insider Filings - BARRETT M JAMES
Last Updated 
3-Aug-15
Enter symbol:
symbol lookup

 

EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search

BARRETT M JAMES: Declared Holdings
Company/RelationshipReportedShares  Ownership
Audience, Inc.
Beneficial Owner (10% or more)
NasdaqGS:ADNC
(historical quotes, other insiders)
4-Nov-13
5-Nov-13
508
   1,439,510
1,440,018
  Direct
  Indirect  
  Total
Ardelyx, Inc.
Beneficial Owner (10% or more)
NasdaqGM:ARDX
(historical quotes, profile, other insiders)
26-Dec-14
5-Jun-15
0
   7,488,893
7,488,893
  Direct
  Indirect  
  Total
Box, Inc. Class A Common Stock
Beneficial Owner (10% or more)
NYSE:BOX
(historical quotes, profile, other insiders)
28-Jan-150  Indirect
CHAMPIONS ONCOLOGY
Beneficial Owner (10% or more)
Other OTC:CSBR
(historical quotes, profile, other insiders)
11-Mar-1518,750,000  Indirect
Tableau Software, Inc. Class A
Beneficial Owner (10% or more)
NYSE:DATA
(historical quotes, profile, other insiders)
2-Dec-14
2-Dec-14
20,522
   83,126
103,648
  Direct
  Indirect  
  Total
GlycoMimetics, Inc.
Director
NasdaqGM:GLYC
(historical quotes, profile, other insiders)
15-Jan-148,575,135  Indirect
INTERLEUKIN GENETICS
Beneficial Owner (10% or more)
Other OTC:ILIU
(historical quotes, profile, other insiders)
23-Dec-1435,298,087  Indirect
Loxo Oncology, Inc.
Director
NasdaqGM:LOXO
(historical quotes, profile, other insiders)
6-Aug-141,789,420  Indirect
Roka Bioscience, Inc.
Director
NasdaqGM:ROKA
(historical quotes, profile, other insiders)
22-Jul-143,216,810  Indirect
Sunesis Pharmaceuticals, Inc.
Beneficial Owner (10% or more)
NasdaqCM:SNSS
(historical quotes, profile, other insiders)
29-Aug-144,659,333  Indirect
Supernus Pharmaceuticals, Inc.
Director
NasdaqGM:SUPN
(historical quotes, profile, other insiders)
15-Jun-15
17-Jun-15
32,524
   7,673,774
7,706,298
  Direct
  Indirect  
  Total
Vitae Pharmaceuticals, Inc.
Beneficial Owner (10% or more)
NasdaqGM:VTAE
(historical quotes, profile, other insiders)
1-Jul-15
1-Jul-15
464
   1,787,698
1,788,162
  Direct
  Indirect  
  Total
Zosano Pharma Corporation
Director
NasdaqCM:ZSAN
(historical quotes, profile, other insiders)
26-Jan-15
30-Jan-15
5
   2,158,539
2,158,544
  Direct
  Indirect  
  Total

Insider & restricted shareholder transactions reported over the last two years
DateSharesStockTransaction
1-Jul-15 *9,384VTAE Acquisition (Non Open Market) at $0 per share.
1-Jul-15 *833,250VTAE Disposition (Non Open Market) at $0 per share.
1-Jul-15 464VTAE Acquisition (Non Open Market) at $0 per share.
17-Jun-15 *111,881SUPN Sale at $16.02 - $16.67 per share.
(Proceeds of about $1,829,000)
16-Jun-15 *55,105SUPN Sale at $16.85 per share.
(Proceeds of $928,519)
15-Jun-15 32,524SUPN Acquisition (Non Open Market) at $0 per share.
15-Jun-15 *1,120,510SUPN Acquisition (Non Open Market) at $0 per share.
15-Jun-15 *3,921,000SUPN Disposition (Non Open Market) at $0 per share.
5-Jun-15 *1,869,159ARDX Purchase at $10.70 per share.
(Cost of $20,000,001)
11-Mar-15 *18,750,000CSBR Statement of Ownership
30-Jan-15 *23,457ZSAN Purchase at $11 per share.
(Cost of $258,027)
30-Jan-15 *341,201ZSAN Acquisition (Non Open Market) at $9.35 per share.
(Value of $3,190,229)
28-Jan-15 *2,091,457BOX Disposition (Non Open Market)
28-Jan-15 *1,928,677BOX Acquisition (Non Open Market)
26-Jan-15 *1,793,881ZSAN Statement of Ownership
26-Jan-15 5ZSAN Statement of Ownership
22-Jan-15 *162,780BOX Statement of Ownership
26-Dec-14 296ARDX Sale at $21.54 per share.
(Proceeds of $6,375)
26-Dec-14 *2,268ARDX Sale at $21.28 - $21.54 per share.
(Proceeds of about $49,000)
23-Dec-14 *2,268ARDX Acquisition (Non Open Market) at $0 per share.
23-Dec-14 296ARDX Acquisition (Non Open Market) at $0 per share.
23-Dec-14 *10,000ARDX Disposition (Non Open Market) at $0 per share.
23-Dec-14 *19,868,965ILIU Purchase at $0.10 per share.
(Cost of $1,986,896)
2-Dec-14 *1,716,876DATA Acquisition (Non Open Market) at $0 per share.
2-Dec-14 13,553DATA Acquisition (Non Open Market) at $0 per share.
2-Dec-14 *1,633,750DATA Disposition (Non Open Market) at $0 per share.
29-Aug-14 *11,600SNSS Sale at $7.51 per share.
(Proceeds of $87,116)
28-Aug-14 *146,800SNSS Sale at $7.87 per share.
(Proceeds of $1,155,316)
27-Aug-14 *108,300SNSS Sale at $8.17 per share.
(Proceeds of $884,811)
25-Aug-14 *7,099DATA Sale at $60.40 per share.
(Proceeds of $428,779)
22-Aug-14 *52,312DATA Sale at $60.46 - $61.02 per share.
(Proceeds of about $3,177,000)
21-Aug-14 10,455DATA Sale at $59.73 - $60.56 per share.
(Proceeds of about $629,000)
21-Aug-14 *47,424DATA Sale at $59.19 - $60.65 per share.
(Proceeds of about $2,842,000)
20-Aug-14 17,424DATA Acquisition (Non Open Market) at $0 per share.
20-Aug-14 *2,100,474DATA Disposition (Non Open Market) at $0 per share.
20-Aug-14 *2,207,309DATA Acquisition (Non Open Market) at $0 per share.
12-Aug-14 *35,540SNSS Sale at $6.76 per share.
(Proceeds of $240,250)
8-Aug-14 *675,000SNSS Sale at $6.62 per share.
(Proceeds of $4,468,500)
6-Aug-14 *1,558,651LOXO Acquisition (Non Open Market)
6-Aug-14 *230,769LOXO Purchase at $13 per share.
(Cost of $2,999,997)
22-Jul-14 *2,828,743ROKA Acquisition (Non Open Market)
22-Jul-14 *383,333ROKA Purchase at $12 per share.
(Cost of $4,599,996)
16-Jul-14 *4,734ROKA Statement of Ownership
7-Mar-14 *23,624DATA Sale at $90.62 - $93.07 per share.
(Proceeds of about $2,170,000)
6-Mar-14 *50,000DATA Sale at $94.32 - $96.13 per share.
(Proceeds of about $4,761,000)
5-Mar-14 *35,000DATA Sale at $94.28 - $95.34 per share.
(Proceeds of about $3,318,000)
5-Mar-14 *17,424DATA Sale at $95.50 per share.
(Proceeds of $1,663,992)
5-Mar-14 17,425DATA Sale at $95.50 per share.
(Proceeds of $1,664,087)
4-Mar-14 *2,207,326DATA Acquisition (Non Open Market) at $0 per share.
4-Mar-14 17,425DATA Acquisition (Non Open Market) at $0 per share.
4-Mar-14 *10,804DATA Sale at $97.31 per share.
(Proceeds of $1,051,337)
4-Mar-14 *2,100,474DATA Disposition (Non Open Market) at $0 per share.
3-Mar-14 *30,000DATA Sale at $95.14 - $96 per share.
(Proceeds of about $2,867,000)
27-Feb-14 34,848DATA Sale at $94.90 per share.
(Proceeds of $3,307,075)
27-Feb-14 *153,604DATA Sale at $94.47 - $97.11 per share.
(Proceeds of about $14,714,000)
26-Feb-14 *4,414,553DATA Acquisition (Non Open Market) at $0 per share.
26-Feb-14 34,848DATA Acquisition (Non Open Market) at $0 per share.
26-Feb-14 *4,200,949DATA Disposition (Non Open Market) at $0 per share.
15-Jan-14 *1,000,000GLYC Purchase at $8 per share.
(Cost of $8,000,000)
15-Jan-14 *6,988,160GLYC Acquisition (Non Open Market)
9-Jan-14 *586,975GLYC Statement of Ownership
5-Nov-13 *2,573ADNC Sale at $9.83 per share.
(Proceeds of $25,292)
4-Nov-13 *1,453,393ADNC Disposition (Non Open Market) at $0 per share.
4-Nov-13 508ADNC Acquisition (Non Open Market) at $0 per share.
4-Nov-13 *17,471ADNC Acquisition (Non Open Market) at $0 per share.
    * Indicates that some (or all) shares are held indirectly (e.g. in a trust, by a spouse, etc.)



EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search


Copyright © 2015 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Data and information are provided by EDGAR Online, Inc. for informational purposes only and not intended for trading purposes. Yahoo!, EDGAR Online, Inc. shall have no liability for the accuracy of the information furnished or for delays, omissions or opinions expressed therein. You may not use the information for any illegal purpose or furnish the information to any person, firm, or branch office for commercial re-use or re-sale.

Questions or Comments?